Simon Pernot

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Jun 14, 2025
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.

Camille Evrard, Antoine Pelras, Simon Rivet

|Dec 15, 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Clémence Flecchia, Edouard Auclin, Emily Alouani

|Jan 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.

Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin

|Jun 09, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.

Simon Pernot, Olivier Pellerin, Pascal Artru

|Jul 04, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

Simon Pernot, Magali Terme, Nina Radosevic-Robin

Pageof 2

Frequent Collaborators

4 joint publications

Julien Taieb

3 joint publications

David Tougeron

2 joint publications

Christelle De La Fouchardière

2 joint publications

Julien Edeline